Harm Reduction and Substance Use
Outline and Key Points covered by this training includes:
- Framing the Issue.
- Defining Harm Reduction.
- The Movement.
- The Evidence.
- Safer Use Best Practices.
Target Audience
This course is designed for health care professionals including physicians, nurses, patients and caregivers, among others.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Define and summarize the principles of harm reduction
- Review the history of the harm reduction movement
- Discuss the importance and impact of harm reduction practices at patient and population-level outcomes.
- Describe safer use best practices for different routes of administration
Disclaimer Statement:
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Course Directors:
Margaret Shang, MD - Clinical Instructor of Medicine, Division of General Internal Medicine, University of Pittsburgh. Addiction Medicine, University of Pittsburgh Medical Center
Conflict of Interest Disclosure:
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
DEA Medication Access and Training Expansion (MATE) Act
This training is designed to meet the training requirements for the Medication Access and Training Expansion (MATE) Act of 2023.
Pennsylvania Opioid/Pain Management Credit (physicians only)
This activity has been designated as and qualifies for Opioid/Pain Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purpose
Available Credit
- 0.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.50 Opioid Education
- 0.50 Attendance
- 0.50 Opioid Education
Choose Register/Complete Course to complete the module.
First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.
Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.